Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Exchange Rate Effect (2021 - 2024)

Pasithea Therapeutics (KTTA) has disclosed Exchange Rate Effect for 4 consecutive years, with $28146.0 as the latest value for Q4 2024.

  • Quarterly Exchange Rate Effect rose 818.3% to $28146.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$2519.0 through Dec 2024, up 36.88% year-over-year, with the annual reading at $18766.0 for FY2025, 844.98% up from the prior year.
  • Exchange Rate Effect hit $28146.0 in Q4 2024 for Pasithea Therapeutics, up from -$27133.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $139421.0 in Q4 2022 to a low of -$82515.0 in Q3 2022.
  • Historically, Exchange Rate Effect has averaged -$347.07 across 4 years, with a median of -$2697.5 in 2023.
  • Biggest YoY gain for Exchange Rate Effect was 2150.61% in 2022; the steepest drop was 5590.69% in 2022.
  • Year by year, Exchange Rate Effect stood at -$6799.0 in 2021, then surged by 2150.61% to $139421.0 in 2022, then tumbled by 97.8% to $3065.0 in 2023, then surged by 818.3% to $28146.0 in 2024.
  • Business Quant data shows Exchange Rate Effect for KTTA at $28146.0 in Q4 2024, -$27133.0 in Q3 2024, and -$2912.0 in Q2 2024.